4.7.20 | Coronavirus
Coronavirus Is Driving a Telehealth Evolution
The coronavirus pandemic has caused an unprecedented and swift change in access to health care. Mental health professionals have been some of the first health care providers to switch full time to telehealth during this crisis.
4.6.20 | Policy
FDA’s Quest to Address Disparities in Medical Devices for Women
Recognizing sex and gender disparities and the pressing issues they present for the health of women, the FDA recently launched the Health of Women Program to foster and advance device innovation for women.
4.1.20
Society for Women’s Health Research Names Kathryn Schubert as President and CEO
SWHR announced the hiring of Kathryn G. Schubert as the organization’s new president and chief executive officer, effective April 27, 2020.
3.25.20
The Importance of Engaging and Supporting Women in STEM
In all facets of STEM, we need to cultivate environments that are more inclusive and diverse by recruiting and supporting girls and women in STEM careers.
3.16.20 | Endometriosis
Adenomyosis: The Common Gynecological Condition You’ve Never Heard Of
Heavy menstrual bleeding, painful cramps, and bloating during menstruation may sound like “normal” mild symptoms accompanying a woman’s period, but for some women, these symptoms are much more severe and may be signs of an undiagnosed, noncancerous gynecological condition.
3.9.20 | Policy
How Options for Disease Screening and Diagnosis Can Affect Women’s Health
Understanding the complicated world of screening and diagnostic testing can help patients better grasp the possibilities for their care.
3.2.20 | Bone Health
Experts Identify Knowledge Gaps in Chronic Osteoarthritis Pain in Women
SWHR brought together researchers and clinicians for a roundtable meeting to identify unmet needs and knowledge gaps for women with osteoarthritis.
2.27.20 | Policy
Ovarian Cancer: Challenges in Diagnostic Innovation
Most women will never be screened for ovarian cancer. Unlike with breast and cervical cancers, ovarian cancer research has struggled to produce reliable methods of screening.
2.21.20 | Research and Clinical Trials
Women Make Up 72% of Study Participants for FDA-Approved New Drugs in 2019
SWHR is thrilled with the news that women accounted for 72% of all clinical trial participants for FDA-approved new drugs in 2019.
